OrbusNeich Medical Group Holdings Limited (stock code: 06929) reported its monthly return on movements in securities for November 2025. Authorized share capital remained at 1.2 billion ordinary shares with a par value of USD 0.0005, totaling USD 600,000, unchanged from the previous month.

The total number of issued ordinary shares stayed at 827,968,337 with no treasury shares as of the end of November. There were no new shares issued during the reporting period.

Under the Pre-IPO Share Option Scheme, 27,500 options lapsed in November, leaving 7,721,000 options outstanding at month-end. For the Post-IPO Share Option Scheme, 35,000 options lapsed, resulting in 4,459,500 outstanding options by the close of the month. No share options were exercised, and no proceeds were raised during the period.